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Clinical trial statistical analysis and reporting is a formidable task. A final study report 
requires the creation of hundreds of tables and data listings, and the calculation of over 
one thousand statistical significance levels, difference estimates and confidence limits. 
Typically, several database programmers, statistical programmers and biostatisticians 
are needed to perform this task over a period of time that is measured in months. We 
describe the design approaches and the evaluation of an intelligent data analysis system 
that automates the creation of clinical trial statistical reports, DART, which is one 
component of an integrative Clinical Trials Information System. This application was 
developed in Stata programming language and has about 9,000 lines of code. This 
unsupervised knowledge-based system is able to select, according to the characteristics 
of the study design, the study statistical analysis plan and the type of baseline and 
efficacy variables used, which are all encoded and stored in the database, the statistical 
methods adequate for each analysis and the results that need to be reported. The entire 
process of data analysis and reporting can be performed automatically, or the user may 
specify some parameters of the analysis (e.g., scale transformations, adjustment for 
confounding). The application can handle commonly used statistical methods applied to 
clinical trials analyses for nominal, multi-valued, ordinal, interval and event/count data 
in one-, two- and multiple-arm trials, crossover studies and factorial designs, with or 
without stratification. It handles imputation of missing data, scale transformations and 
regrouping of study centers. It can automatically select baseline variables for inclusion 
as covariates, and to conduct post-stratification analyses and subgroup analyses. So far, 
DART has been successfully used for the automated statistical reporting of 35 
pharmaceutical clinical trials. In a validation study, the statistical methods used in a 
random sample of 51 clinical trials published in The New England Journal of Medicine 
and in The Lancet, reporting 97 different analysis, the analytical methods were identical 
or equivalent to those selected by DART in 84.5%, different in 6.2% and not supported 
by DART in 9.3%.  
 
 
 
 